Compositions having neuroprotective and analgesic activity
    1.
    发明授权
    Compositions having neuroprotective and analgesic activity 失效
    具有神经保护和止痛活性的组合物

    公开(公告)号:US06410537B1

    公开(公告)日:2002-06-25

    申请号:US09541431

    申请日:2000-04-03

    IPC分类号: A61K31395

    CPC分类号: A61K31/4965

    摘要: Compounds of the formula: wherein R1 and R2 are alkyl of 1-8 carbons have been shown to have both neuroprotective and analgesic activities. The compounds of the invention may be used in treatment of conditions that would normally result in neuronal damage, including those arising on account of cerebral ischemia/hypoxia or increase in intracranial pressure such as neoplasms, stroke, meningitis or trauma and for treatment of pain. Compositions of the invention can also be useful for treatment of toxin-related damage such as drug over-dose or exposure to toxins in the environment.

    摘要翻译: 其中R1和R2为1-8个碳原子的烷基化合物已显示具有神经保护作用和止痛活性。 本发明的化合物可用于治疗通常导致神经元损伤的病症,包括因脑缺血/缺氧或颅内压升高如颅内压,脑膜炎或创伤引起的疾病和治疗疼痛。 本发明的组合物还可用于治疗毒素相关的损伤,例如药物过量或暴露于环境中的毒素。

    Compositions having neuroprotective and analgesic activity
    2.
    发明授权
    Compositions having neuroprotective and analgesic activity 失效
    具有神经保护和止痛活性的组合物

    公开(公告)号:US6046200A

    公开(公告)日:2000-04-04

    申请号:US9307

    申请日:1998-01-20

    CPC分类号: A61K31/4965

    摘要: Compounds of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are alkyl of 1-8 carbons have been shown to have both neuroprotective and analgesic activities. The compounds of the invention may be used in treatment of conditions that would normally result in neuronal damage, including those arising on account of cerebral ischemia/hypoxia or increase in intracranial pressure such as neoplasms, stroke, meningitis or trauma. Compositions of the invention can also be useful for treatment of toxin-related damage such as drug over-dose or exposure to toxins in the environment.

    摘要翻译: 其中R1和R2为1-8个碳原子的烷基化合物已显示具有神经保护作用和止痛活性。 本发明的化合物可用于治疗通常导致神经元损伤的病症,包括因脑缺血/缺氧或颅内压升高如赘生物,中风,脑膜炎或创伤引起的损伤。 本发明的组合物还可用于治疗毒素相关的损伤,例如药物过量或暴露于环境中的毒素。

    Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for
CNS disorders
    3.
    发明授权
    Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders 失效
    用于CNS疾病的含氮环杂环芳基芳基衍生物

    公开(公告)号:US5856318A

    公开(公告)日:1999-01-05

    申请号:US910302

    申请日:1997-08-11

    摘要: Certain nitrogen-containing cyclohetero cycloalkylaminoaryl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein each of R.sup.1, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is independently selected from hydrido, lower alkyl, benzyl, and haloloweralkyl;wherein each of R.sup.2, R.sup.3 and R.sup.8 through R.sup.11 is independently selected from hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; wherein n is an integer of from four to six; wherein m is an integer of from two to four; wherein A is selected from phenyl, naphthyl, benzothienyl, benzofuranyl and thienyl; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 描述某些含氮环杂环烷基氨基芳基化合物用于治疗中枢神经系统疾病如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中R 1,R 4,R 5,R 6和R 7各自独立地选自氢,低级烷基,苄基和卤代低级烷基; 其中R2,R3和R8至R11各自独立地选自氢,羟基,低级烷基,苄基,苯氧基,苄氧基和卤代低级烷基; 其中n为4-6的整数; 其中m是2至4的整数; 其中A选自苯基,萘基,苯并噻吩基,苯并呋喃基和噻吩基; 其中前述A基团中的任一个可以进一步被一个或多个独立地选自氢,羟基,低级烷基,低级烷氧基,卤素,卤代低级烷基,氨基,单低级烷基氨基和二低级烷基氨基的取代基取代。 或其药学上可接受的盐。

    Aralkyl diazabicycloalkane derivatives for CNS disorders
    4.
    发明授权
    Aralkyl diazabicycloalkane derivatives for CNS disorders 失效
    用于CNS病症的芳烷基二氮杂双环烷烃衍生物

    公开(公告)号:US5679679A

    公开(公告)日:1997-10-21

    申请号:US348654

    申请日:1994-12-02

    摘要: Certain aralkyl diazabicyloalkyl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein: each of R.sup.1, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is independently selected from the group consisting of hydrido, loweralkyl, benzyl and haloloweralkyl; each of R.sup.2, R.sup.3, and R.sup.8 through R.sup.11 is independently selected from the group consisting of hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; n is an integer of from three to four; m is an integer of two; A is selected from the group consisting of phenyl, naphthyl, benzothienyl, benzofuranyl and thienyl and wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from the group consisting of hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 描述了某些芳烷基二氮杂双环烷基化合物用于治疗中枢神经系统疾病如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中:R 1,R 4,R 5,R 6和R 7各自独立地选自氢,低级烷基,苄基和卤代低级烷基; R 2,R 3和R 8至R 11各自独立地选自氢,羟基,低级烷基,苄基,苯氧基,苄氧基和卤代低级烷基; n是3至4的整数; m是2的整数; A选自苯基,萘基,苯并噻吩基,苯并呋喃基和噻吩基,其中任何前述A基团可以进一步被一个或多个独立地选自羟基,羟基,低级烷基,低级烷氧基,卤代 ,卤代低级烷基,氨基,单低级烷基氨基和二低级烷基氨基; 或其药学上可接受的盐。

    Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
    5.
    发明授权
    Aralkyl bridged diazabicycloalkane derivatives for CNS disorders 失效
    用于CNS病症的芳烷基桥连二氮杂双环烷烃衍生物

    公开(公告)号:US5679673A

    公开(公告)日:1997-10-21

    申请号:US344304

    申请日:1994-11-21

    CPC分类号: C07D487/08 C07D453/02

    摘要: Certain aralkyl diazabicycloalkyl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein each of R, R.sup.1, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is independently selected from hydrido, lower-alkyl, benzyl, and haloloweralkyl; wherein each of R.sup.2, R.sup.3 and R.sup.10 through R.sup.13 is independently selected from hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; wherein each of R.sup.8 and R.sup.9 is selected from hydrido, loweralkyl, benzyl and haloloweralkyl; wherein m is an integer of from two to four; wherein A is selected from phenyl, naphthyl, benzothiophenyl, benzofuranyl and thienyl; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 描述了某些芳烷基二氮杂双环烷基化合物用于治疗中枢神经系统疾病如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中R,R 1,R 4,R 5,R 6和R 7各自独立地选自氢,低级烷基,苄基和卤代低级烷基; 其中R2,R3和R10至R13各自独立地选自氢,羟基,低级烷基,苄基,苯氧基,苄氧基和卤代低级烷基; 其中R8和R9各自选自氢,低级烷基,苄基和卤代低级烷基; 其中m是2至4的整数; 其中A选自苯基,萘基,苯并噻吩基,苯并呋喃基和噻吩基; 其中前述A基团中的任一个可以进一步被一个或多个独立地选自氢,羟基,低级烷基,低级烷氧基,卤素,卤代低级烷基,氨基,单低级烷基氨基和二低级烷基氨基的取代基取代。 或其药学上可接受的盐。

    Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS
disorders
    6.
    发明授权
    Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders 失效
    用于CNS疾病的含氮环杂环芳基氨基芳基衍生物

    公开(公告)号:US5346908A

    公开(公告)日:1994-09-13

    申请号:US904354

    申请日:1992-06-25

    摘要: Certain nitrogen-containing cyclohetero cycloalkylaminoaryl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein each of R.sup.1, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is independently selected from hydrido, lower alkyl, benzyl, and haloloweralkyl; wherein each of R.sup.2, R.sup.3 and R.sup.8 through R.sup.11 is independently selected from hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; wherein n is an integer of from four to six; wherein m is an integer of from two to four; wherein A is selected from phenyl, naphthyl, benzothienyl, benzofuranyl and thienyl; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 描述某些含氮环杂环烷基氨基芳基化合物用于治疗中枢神经系统疾病如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中R 1,R 4,R 5,R 6和R 7各自独立地选自氢,低级烷基,苄基和卤代低级烷基; 其中R2,R3和R8至R11各自独立地选自氢,羟基,低级烷基,苄基,苯氧基,苄氧基和卤代低级烷基; 其中n为4-6的整数; 其中m是2至4的整数; 其中A选自苯基,萘基,苯并噻吩基,苯并呋喃基和噻吩基; 其中前述A基团中的任一个可以进一步被一个或多个独立地选自氢,羟基,低级烷基,低级烷氧基,卤素,卤代低级烷基,氨基,单低级烷基氨基和二低级烷基氨基的取代基取代。 或其药学上可接受的盐。

    Methods of O-demethylation and N-deprotection
    8.
    发明授权
    Methods of O-demethylation and N-deprotection 失效
    O-去甲基化和N-去保护的方法

    公开(公告)号:US06395900B1

    公开(公告)日:2002-05-28

    申请号:US09895956

    申请日:2001-06-29

    IPC分类号: C07D48902

    摘要: The present invention provides a method for N-deprotecting an opioid compound, a method for N-deprotecting and O-demethylating an opioid compound, a method for O-demethylating an opioid compound, and a method for O-demethylating a nonpeptidic delta agonist compound or an opioid compound having a tertiary amide with no significant reaction at amide groups.

    摘要翻译: 本发明提供了对阿片样物质进行N-去保护的方法,对于阿片样物质进行N-脱保护和O-脱甲基化的方法,对阿片样物质进行O-去甲基化的方法,以及将非肽δ激动剂化合物O-脱甲基化的方法 或具有在酰胺基上没有显着反应的叔酰胺的阿片样物质化合物。

    Aralkyl diazabicycloalkane derivatives for CNS disorders
    10.
    发明授权
    Aralkyl diazabicycloalkane derivatives for CNS disorders 失效
    用于CNS病症的芳烷基二氮杂双环烷烃衍生物

    公开(公告)号:US5958920A

    公开(公告)日:1999-09-28

    申请号:US954284

    申请日:1997-10-20

    摘要: Certain aralkyl diazabicycloalkyl compounds are disclosed for treatment of CNS disorders, such as cerebral ischemia, psychosis and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein m is three or four; wherein z is selected from the group consisting of ##STR2## wherein when Z is ##STR3## n and p are integers of from one to four, with a sum of four or five, and when Z is ##STR4## n and p are integers of from one to three, with a sum of three or four; wherein A is selected from the group consisting of aryl, heteroaryl, aryloxy, heteroaryloxy, aralkoxy, heteroaralkoxy, arylamino, heteroarylamino, aralkylamino, heteroaralkylamino, arylthio, heteroarylthio, aralkylthio, and heteroaralkylthio; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from the group consisting of hydrido, hydroxy, alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, alkoxy, aryloxy, aralkoxy, alkoxyalkyl, halo, haloalkyl, hydroxyalkyl, cyano, amino, monoalkylamino, dialkylamino, carboxy, carboxyalkyl, alkanoyl, alkenyl and alkynyl; or a pharmaceutically acceptable salt thereof.

    摘要翻译: 公开了某些芳烷基二氮杂双环烷基化合物用于治疗中枢神经系统疾病,如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中m为三或四; 其中z选自其中当Z为n且p为1至4的整数时,其总数为4或5,当Z为n且p为1至3的整数时,其总和为 三或四; 其中A选自芳基,杂芳基,芳氧基,杂芳氧基,芳烷氧基,杂芳烷氧基,芳基氨基,杂芳基氨基,芳烷基氨基,杂芳烷基氨基,芳硫基,杂芳硫基,芳烷硫基和杂芳烷硫基。 其中前述A基团中的任一个可以进一步被一个或多个独立地选自羟基,羟基,烷基,环烷基,环烷基烷基,芳烷基,芳基,烷氧基,芳氧基,芳烷氧基,烷氧基烷基,卤素,卤代烷基, ,氰基,氨基,单烷基氨基,二烷基氨基,羧基,羧基烷基,烷酰基,烯基和炔基; 或其药学上可接受的盐。